Your browser doesn't support javascript.
loading
Von Willebrand Disease: Gaining a global perspective.
O'Sullivan, Jamie M; Tootoonchian, Ellia; Ziemele, Baiba; Makris, Michael; Federici, Augusto B; Khayat Djambas, Claudia; El Ekiaby, Magdy; Rotellini, Dawn; Sidonio, Robert F; Iorio, Alfonso; Coffin, Donna; Pierce, Glenn F; Stonebraker, Jeffrey; James, Paula D; Lavin, Michelle.
Afiliación
  • O'Sullivan JM; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences RSCI, Dublin, Ireland.
  • Tootoonchian E; World Federation of Hemophilia, Montreal, Quebec, Canada.
  • Ziemele B; World Federation of Hemophilia, Montreal, Quebec, Canada.
  • Makris M; Latvia Haemophilia Society, Riga, Latvia.
  • Federici AB; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Khayat Djambas C; Department of Oncology and Haematology Oncology, University of Milan, School of Medicine, Milan, Italy.
  • El Ekiaby M; Department of Pediatrics, Hotel Dieu de France Hospital Beirut, Saint Joseph University, Beirut, Lebanon.
  • Rotellini D; Hemophilia Treatment Center, Shabrawishi Hospital, Giza, Egypt.
  • Sidonio RF; World Federation of Hemophilia, Montreal, Quebec, Canada.
  • Iorio A; National Hemophilia Foundation, New York, New York, USA.
  • Coffin D; Aflac Cancer and Blood Disorders, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Pierce GF; Professor and Chair, Department of Health Care Research, Department of Health Research Methods, Evidence, and Impact (HEI), Mike Gent Chair in Healthcare Research, McMaster University, Hamilton, Ontario, Canada.
  • Stonebraker J; World Federation of Hemophilia, Montreal, Quebec, Canada.
  • James PD; World Federation of Hemophilia, Montreal, Quebec, Canada.
  • Lavin M; Poole College of Management, North Carolina State University, Raleigh, North Carolina, USA.
Haemophilia ; 29(4): 1104-1112, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37216656
ABSTRACT

INTRODUCTION:

Recent guidelines for von Willebrand Disease (VWD) highlighted the challenges in diagnosis and management. Identifying the number of persons with VWD (PwVWD) internationally will help target support to aid diagnosis of PwVWD.

AIM:

To examine international registration rates of PwVWD, the influence of income status, geographical region and the age and sex profile. Cumulatively, these data will be used to inform future strategy from the World Federation of Haemophilia (WFH) to address unmet clinical and research needs.

METHODS:

Data from the 2018/2019 WFH Annual Global Survey (AGS) were analysed, providing a global perspective on VWD registration.

RESULTS:

Registration rates are lowest in South Asia (0.6/million population) and highest in Europe/Central Asia (50.9/million population, 0.005%), but below the expected prevalence rate (0.1%). National economic status impacted VWD registration rates, reflecting variation in access to optimal healthcare infrastructure. Females represented the majority of PwVWD globally, however, in low-income countries (LIC) males predominated. Age profile varied, with markedly higher rates of paediatric registrations in North America, Middle East and North Africa and South Asia. Rates of type 3 VWD registrations were significantly influenced by economic status (81% of VWD diagnoses in LIC), suggesting only the most severe VWD types are diagnosed in resource limited settings.

CONCLUSION:

Significant variation in registration rates of PwVWD exist internationally and is influenced by income status and the presence of HTC networks. Improved understanding of registration rates will enable targeting of advocacy to improve awareness, diagnosis and support for PwVWD internationally. KEY POINTS Registration rates of People with Von Willebrand Disease (PwVWD) vary internationally and are influenced by national income status Although females represent the majority of PwVWD globally, in low income countries (LIC) males predominated, possibly related to stigma surrounding gynaecological bleeding. Rates of type 3 VWD registration were significantly influenced by economic status (81% of VWD diagnoses in LIC), suggesting only the most severe VWD types are diagnosed in resource limited settings.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de von Willebrand / Enfermedad de von Willebrand Tipo 3 / Hemofilia A Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Child / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Haemophilia Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de von Willebrand / Enfermedad de von Willebrand Tipo 3 / Hemofilia A Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Child / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Haemophilia Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Irlanda